Supportive care is not the only option in prostate cancer patients resistant to hormone therapy: The argument for Conference Paper
| Author: | Scher, H. I. |
| Title: | Supportive care is not the only option in prostate cancer patients resistant to hormone therapy: The argument for |
| Conference Title: | International Congress on Prostate Cancer: Current Issues, New Approaches |
| Abstract: | In multivariable analyses conducted by several groups, a post-therapy decline in prostate specific antigen was the most significant factor associated with survival of patients with relapsed prostate cancer. Contemporary combination regimens result in consistent declines in prostate-specific antigen in up to 40% of cases, along with objective tumour regression, and the improvement in cancer-related symptoms. It is, therefore, apparent that prostate cancers are not as resistant to treatment as previously believed. |
| Keywords: | cancer survival; treatment outcome; bone neoplasms; conference paper; combined modality therapy; cancer palliative therapy; prostate specific antigen; neoplasm recurrence, local; antineoplastic combined chemotherapy protocols; relapse; drug resistance, neoplasm; prostate cancer; prostate-specific antigen; prostatic neoplasms; symptom; multivariate analysis; antineoplastic agents, hormonal; hormone; analysis of variance; cytoskeleton; clinical trials; supportive care; humans; human; male; priority journal; hormone-resistance |
| Journal Title | European Urology |
| Volume: | 29 |
| Issue: | Suppl. 2 |
| Conference Dates: | 1995 Oct 19-21 |
| Conference Location: | London, England |
| ISBN: | 0302-2838 |
| Publisher: | Elsevier Science, Inc. |
| Date Published: | 1996-01-01 |
| Start Page: | 40 |
| End Page: | 44 |
| Language: | English |
| PUBMED: | 8717462 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Conference Paper -- Export Date: 22 November 2017 -- Source: Scopus |
